Badrilla Ltd，成立于2003年，是一家的生命科学公司，为主要制药，生物技术和学术机构中的分子心血管研究人员提供高质量的产品。Badrilla协助研究人员将有机化学和蛋白质化学方面的专业知识与蛋白质的翻译后修饰知识相结合，以协调心脏的兴奋与收缩耦合，心律失常和肥大以及导致心力衰竭的适应不良反应，从而在过去的十年中，Badrilla产品帮助巩固了心脏生物化学领域的重要发现，并且该公司从科学家那里获得了大量已发表的数据。
上海金畔Badrilla2021年价格表
| 货号 | 品名 | 规格 | 价格 | 品牌 |
| K010-310 | CAPTUREomeTM S-Palmitoylated Protein Mini Kit | Kit | 3552.15 | Badrilla2021 |
| K010-311 | CAPTUREomeTM S-Palmitoylated Protein Kit | Kit | 8907.15 | Badrilla2021 |
| K010-312 | SiteCounter S-Palmitoylated Protein kit | Kit | 8907.15 | Badrilla2021 |
| K010-313 | SiteCounter S-Palmitoylated Protein Mini kit | Kit | 3552.15 | Badrilla2021 |
| K010-410 | Click S-Palmitoylation Detection-775 Kit | Kit | 8015.364 | Badrilla2021 |
| A010-701 | ML348 (inhibitor of acyl palmitoyl thio-esterase 1 (APT1)) | 1 mg | 1071 | Badrilla2021 |
| A010-702 | ML349 (inhibitor of acyl palmitoyl thio-esterase 2 (APT2)) | 1 mg | 1071 | Badrilla2021 |
| A010-601 | AccuMarQ Pre-stained Molecular Weight Markers (10-240kDa) | Kit | 1963.5 | Badrilla2021 |
| A010-10AP | Phospholamban (PLN,PLB) (pSer10) pAb affinity purified | 50ug | 5801.25 | Badrilla2021 |
| A010-12 | Phospholamban (PLN, PLB) (pSer16) pAb serum | 25µl | 5801.25 | Badrilla2021 |
| A010-12AP | Phospholamban (PLN, PLB) (pSer16) pAb affinity purified | 50µl | 9728.25 | Badrilla2021 |
| A010-13 | Phospholamban (PLN, PLB) (pThr17) pAb serum | 25µl | 5801.25 | Badrilla2021 |
| A010-13AP | Phospholamban (PLN, PLB) (pThr17) pAb affinity purified | 100µl | 9728.25 | Badrilla2021 |
| A010-14 | Phospholamban (PLN, PLB) mAb (clone A1) | 25µg | 5801.25 | Badrilla2021 |
| A010-110 | Phospholemman (PLM) (pSer63) pAb | 100ml | 5801.25 | Badrilla2021 |
| A010-111 | Phospholemman (PLM) (pSer68) pAb | 100ml | 5801.25 | Badrilla2021 |
| A010-112 | Phospholemman (PLM) (pThr69) pAb | 100ml | 5801.25 | Badrilla2021 |
| A010-113 | Phospholemman (PLM) (Ser68/pThr69) pAb | 100ml | 5801.25 | Badrilla2021 |
| A010-20 | SERCA2a pAb serum | 20µl | 5801.25 | Badrilla2021 |
| A010-21AP | SERCA1/2 mAb (clone Y/1F4) | 50µl | 5801.25 | Badrilla2021 |
| A010-22AP | SERCA1 mAb (clone B/4H3) | 50µl | 5801.25 | Badrilla2021 |
| A010-23L | SERCA2a pAb serum | 100µl | 6515.25 | Badrilla2021 |
| A010-23S | SERCA2a pAb serum | 20µl | 2320.5 | Badrilla2021 |
| A010-24L | SERCA2b pAb serum | 100µl | 6515.25 | Badrilla2021 |
| A010-24S | SERCA2b pAb serum | 20µl | 2320.5 | Badrilla2021 |
| A010-25AP | SERCA2 (pSer38) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
| A010-30 | Ryanodine receptor 2 (RYR2) (pSer2808) pAb serum | 50µl | 10692.15 | Badrilla2021 |
| A010-30AP | Ryanodine receptor 2 (RYR2) (pSer2808) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
| A010-31 | Ryanodine receptor 2 (RYR2) (pSer2814) pAb serum | 50µl | 10692.15 | Badrilla2021 |
| A010-31AP | Ryanodine receptor 2 (RYR2) (pSer2814) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
| A010-32 | Ryanodine receptor 2 (RYR2) (pSer2030) pAb serum | 50µl | 10692.15 | Badrilla2021 |
| A010-35AP | Ryanodine receptor 2 (RYR2) (dephoSer2808) pAb affinity purified | 100µl | 11691.75 | Badrilla2021 |
| A010-514 | DPc10 Peptide | 200mg | 2829.0465 | Badrilla2021 |
| A010-515 | DPc10 Inactive Peptide | 200mg | 2829.0465 | Badrilla2021 |
| A010-516 | Fluorescein DPc10 Peptide | 200mg | 2829.0465 | Badrilla2021 |
| A010-517 | Fluorescein DPc10 Inactive Peptide | 200mg | 2829.0465 | Badrilla2021 |
| A010-519 | DPc10 Cell Permeable Peptide | 1mg | 6024.375 | Badrilla2021 |
| A010-520 | Fluorescein DPc10 Cell permeable peptide | 0.1mg | 2856 | Badrilla2021 |
| A010-50 | CaMKII (pThr286 or 287) pAb serum | 20µl | 5801.25 | Badrilla2021 |
| A010-50AP | CaMKII (pThr286 or 287) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
| A010-56AP | CaMKII delta isoforms (2/3/4/9/11/11a) pAb affinity purified | 100ug (50µl) | 5801.25 | Badrilla2021 |
| A010-2E11 | Nitrotyrosine mAb (clone 2E11) | 50µg | 5801.25 | Badrilla2021 |
| A010-6B2 | Nitrotyrosine mAb (Clone 6B2) | 20µl | 5801.25 | Badrilla2021 |
| A010-513 | Nitrotyrosine Western blot starter pack | Kit | 7497 | Badrilla2021 |
| A010-mCherry-5 | Red fluorescent protein (mCherry) pAb epitope purified | 5ug | 1249.5 | Badrilla2021 |
| A010-mCherry-50 | Red fluorescent protein (mCherry) pAb epitope purified | 50ug | 5801.25 | Badrilla2021 |
| A010-mEOS | mEOS2 pAb | 50ug | 5801.25 | Badrilla2021 |
| A010-myc-5 | c-myc mAb (clone 9E10.2) | 5mg | 1249.5 | Badrilla2021 |
| A010-myc-50 | c-myc mAb (clone 9E10.2) | 200µg | 5801.25 | Badrilla2021 |
| A010-myc-BULK | c-myc mAb (clone 9E10.2) | 1mg | 9371.25 | Badrilla2021 |
| A010-pGFP-5 | Green fluorescent protein (GFP, EGFP) pAb epitope purified | 5ug | 1249.5 | Badrilla2021 |
| A010-pGFP-50 | Green fluorescent protein (GFP, EGFP) pAb epitope purified | 50ug | 5801.25 | Badrilla2021 |
| A-b2AR-100 | β-2 Adrenergic receptor (β-2AR) pAb | 100µl | 5622.75 | Badrilla2021 |
| A-b2AR-25 | β-2 Adrenergic receptor (β-2AR) pAb | 25µl | 1874.25 | Badrilla2021 |
| A010-40AP | Erk 1/2 (pThr188) pAb affinity purified | 50µl | 5801.25 | Badrilla2021 |
| A010-70 | L-type Ca2+ channel (Cav1.2) (pSer1928) pAb | 50µl | 10692.15 | Badrilla2021 |
| A010-80 | Calcineurin (pSer197) pAb serum | 100µl | 5801.25 | Badrilla2021 |